About us

Our Research & Development Strategy

Our Research & Development Strategy for RuthigenAt Ruthigen, our R&D strategy is centered on innovation, safety, and efficacy. We are committed to developing cutting-edge solutions that address critical needs in surgical and trauma care, particularly through our flagship product, RUT58-60, a hypochlorous acid-based drug designed to prevent and treat infections.Key Pillars of Our R&D StrategyInnovation in Antimicrobial Solutions Our primary focus is on creating advanced antimicrobial solutions that offer broad-spectrum protection without contributing to antibiotic resistance. RUT58-60 embodies this approach by utilizing a powerful, fast-acting mechanism that targets multiple pathogens, including bacteria, viruses, and fungi. We continuously invest in research to refine and expand the applications of hypochlorous acid-based treatments.Enhancing Safety and Biocompatibility We prioritize safety and biocompatibility in all our developments. Our R&D team has engineered RUT58-60 to be stable, tissue-compatible, and suitable for direct contact with internal organs. This innovation aims to set a new standard in surgical infection control, ensuring that patients receive safe and effective care.Efficiency and Stability in Drug Formulation Stability is a key challenge in formulating hypochlorous acid-based drugs. Our research efforts are dedicated to enhancing the stability of RUT58-60, ensuring it maintains its potency over an extended shelf life. This makes our product convenient and reliable for use in surgical settings without requiring special handling.Clinical Research and Regulatory Compliance Ruthigen is committed to rigorous clinical research to validate the safety and efficacy of RUT58-60. We conduct extensive non-clinical and clinical studies to meet stringent FDA standards and demonstrate the product’s ability to improve surgical outcomes. Our strategy involves proactive engagement with regulatory authorities to ensure compliance and facilitate a smooth pathway to market approval.Collaborative Development and Innovation Collaboration is at the heart of our R&D approach. We actively seek partnerships with leading research institutions.